These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 23643165)
1. [Changes of protein expression in HepG2 cells with CDK2 RNA interference]. Shang J; Wang Z; Li J Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Apr; 29(4):359-63. PubMed ID: 23643165 [TBL] [Abstract][Full Text] [Related]
2. [The influence of downregulation of ezrin expression by RNA interference on the growth and metastasis of hepatocellular carcinoma: experiment in vitro]. Zhang Y; Hu MY; Chen BH; Wang ZJ; Zha XL; Liu KD Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):530-5. PubMed ID: 16681881 [TBL] [Abstract][Full Text] [Related]
3. [Effect of silencing AEG-1 with small interfering RNA on the proliferation and cell cycle of gastric carcinoma SGC-7901 cells]. Zhang CF; Xia YH; Zheng QF; Li ZJ; Guo XH; Zhou HC; Zhang LL; Dong LP; Han Y; Liu ZE; Wang WJ; Luo YL Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):22-7. PubMed ID: 23648295 [TBL] [Abstract][Full Text] [Related]
4. [Effect of Na(+)/K(+)-ATPase alpha1 siRNA and ouabain upon cell cycle in human hepatoma HepG2 cell and its mechanism]. Xu ZW; Wang FM; Xu RC; Hu WL; Chen XY Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(12):813-7. PubMed ID: 20450619 [TBL] [Abstract][Full Text] [Related]
5. [Inhibitory effect of blocking expression of human augmenter of liver regeneration (hALR) on proliferation of hepatocellular carcinoma cell line HepG2]. Tang L; Sun H; Zhang L; Guo H; Zhang L; Liu Q Ai Zheng; 2006 Jun; 25(6):671-6. PubMed ID: 16764759 [TBL] [Abstract][Full Text] [Related]
6. Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype. Frau M; Ladu S; Calvisi DF; Simile MM; Bonelli P; Daino L; Tomasi ML; Seddaiu MA; Feo F; Pascale RM J Hepatol; 2011 Jul; 55(1):111-9. PubMed ID: 21419759 [TBL] [Abstract][Full Text] [Related]
7. Water extract of Hedyotis Diffusa Willd suppresses proliferation of human HepG2 cells and potentiates the anticancer efficacy of low-dose 5-fluorouracil by inhibiting the CDK2-E2F1 pathway. Chen XZ; Cao ZY; Chen TS; Zhang YQ; Liu ZZ; Su YT; Liao LM; Du J Oncol Rep; 2012 Aug; 28(2):742-8. PubMed ID: 22641337 [TBL] [Abstract][Full Text] [Related]
8. Targeted disruption of S100P suppresses tumor cell growth by down-regulation of cyclin D1 and CDK2 in human hepatocellular carcinoma. Kim JK; Jung KH; Noh JH; Eun JW; Bae HJ; Xie HJ; Ahn YM; Ryu JC; Park WS; Lee JY; Nam SW Int J Oncol; 2009 Dec; 35(6):1257-64. PubMed ID: 19885547 [TBL] [Abstract][Full Text] [Related]
9. [Suppression of c-myc expression by interference RNA in HepG2 hepatocellular carcinoma cells]. Xu Y; Wang YH; Gao JD; Ye J; Zhu HX; Xu NZ; Wang XY; Sun ZT Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):458-60. PubMed ID: 15555332 [TBL] [Abstract][Full Text] [Related]
10. Knockdown of BDNF suppressed invasion of HepG2 and HCCLM3 cells, a mechanism associated with inactivation of RhoA or Rac1 and actin skeleton disorganization. Guo D; Sun W; Zhu L; Zhang H; Hou X; Liang J; Jiang X; Liu C APMIS; 2012 Jun; 120(6):469-76. PubMed ID: 22583359 [TBL] [Abstract][Full Text] [Related]
11. [Construction of shRNA eucharyotic expression plasmid targeted human VIGILIN and the investigation of VIGILIN's effect on hepatocarcinoma cell cycle]. Xie XY; Wei L; Yang WL; Ge YJ; Qin Y Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 39(4):527-30, 539. PubMed ID: 18798485 [TBL] [Abstract][Full Text] [Related]
12. [Effects of COX-2 gene silencing by shRNA on biological characteristics of human hepatocellular carcinoma cell line HepG2]. Xu KS; Wang HF; Qian W; Wang BH Ai Zheng; 2007 Jan; 26(1):32-7. PubMed ID: 17222364 [TBL] [Abstract][Full Text] [Related]
13. [VIGILIN involves in regulation of imprinting gene IGF2 and H19 in human hepatocellular carcinoma cell]. Ge YJ; Xie XY; Yang B; Chai XJ; Zhang YC; Qin Y Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Sep; 40(5):770-4. PubMed ID: 19950580 [TBL] [Abstract][Full Text] [Related]
14. The effect of cell cycle and expression of cyclin B1 and cyclin C protein in hepatocellular carcinoma cell line HepG2 and SMMC-7721 after of silencing β-catenin gene. Wang B; Xunsun ; Liu JY; Yang D; Yang LL; Kong DX; Meng XW Hepatogastroenterology; 2012; 59(114):515-8. PubMed ID: 22024040 [TBL] [Abstract][Full Text] [Related]
15. [Inhibition of SMYD3 gene expression by RNA interference induces apoptosis in human hepatocellular carcinoma cell line HepG2]. Xu JY; Chen LB; Xu JY; Yang Z; Wei HY; Xu RH Ai Zheng; 2006 May; 25(5):526-32. PubMed ID: 16687068 [TBL] [Abstract][Full Text] [Related]
16. [Construction of eukaryotic expression vector encoding ACRBP and its expression in hepatocarcinoma cells]. Luo B; Yun X; Lin YD; Xiao SW; Yan GH; He SJ; He SJ; Chen F; Xie XX Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Oct; 27(10):1072-4. PubMed ID: 21968305 [TBL] [Abstract][Full Text] [Related]
17. NF-κB induces abnormal centrosome amplification by upregulation of CDK2 in laryngeal squamous cell cancer. Liu JL; Ma HP; Lu XL; Sun SH; Guo X; Li FC Int J Oncol; 2011 Oct; 39(4):915-24. PubMed ID: 21769424 [TBL] [Abstract][Full Text] [Related]
18. Downregulation of MiR-93 expression reduces cell proliferation and clonogenicity of HepG2 cells. Xu D; He XX; Chang Y; Sun SZ; Xu CR; Lin JS Hepatogastroenterology; 2012; 59(120):2367-73. PubMed ID: 22773266 [TBL] [Abstract][Full Text] [Related]
19. [Experimental research of targeting hTERT gene inhibited in hepatocellular carcinoma therapy by RNA interference]. Zhang PH; Tu ZG; Yang MQ; Huang WF; Zou L; Zhou YL Ai Zheng; 2004 Jun; 23(6):619-25. PubMed ID: 15191658 [TBL] [Abstract][Full Text] [Related]
20. Zbtb7 suppresses the expression of CDK2 and E2F4 in liver cancer cells: implications for the role of Zbtb7 in cell cycle regulation. Yang X; Zu X; Tang J; Xiong W; Zhang Y; Liu F; Jiang Y Mol Med Rep; 2012 Jun; 5(6):1475-80. PubMed ID: 22447046 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]